| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.8M | +7.4% |
| SG&A Expense | $6.2M | +29.2% |
| Operating Income | -$14.0M | -16.1% |
| Pre-tax Income | -$13.6M | -14.5% |
| Net Income | -$13.6M | -14.5% |
| EPS (Basic) | -$10.36 | -167.7% |
| EPS (Diluted) | -$10.36 | -167.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.5M | +364.8% |
| Current Assets | $5.7M | +202.7% |
| Total Assets | $7.8M | +142.0% |
| Current Liabilities | $2.2M | +45.9% |
| Total Liabilities | $2.2M | +45.9% |
| Stockholders' Equity | $5.6M | +228.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.4M | -1.2% |
| Investing Cash Flow | -$850K | — |
| Financing Cash Flow | $16.6M | +114.4% |